Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high performance liquid chromatography with native fluorescence detection

被引:38
作者
Concheiro, M [1 ]
de Castro, A [1 ]
Quintela, O [1 ]
López-Rivadulla, M [1 ]
Cruz, A [1 ]
机构
[1] Univ Santiago de Compostela, Inst Legal Med, Forens Toxicol Serv, Santiago De Compostela 15782, Spain
关键词
MDMA; MDA; MDEA; MBDB; oral fluid; HPLC; fluorescence;
D O I
10.1016/j.forsciint.2004.12.041
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
This paper describes the analytical methodology for the determination of MDMA, MDA, MDEA and MBDB in oral fluid. After a liquid-liquid extraction, the analysis was carried out by high performance liquid chromatography (HPLC), with fluorescence detection. The detector wavelength was fixed at 285 nm for excitation and 320 urn for emission. The mobile phase, a mixture of phosphate buffer (pH = 5) and acetonitrile (75:25), and the column, Kromasil 100 C8 5 mu m 250 mm x 4.6 mm, allowed good separation of the compounds in an isocratic mode in only 10 min. The method was validated and showed good limits of detection (2 ng/mL) and quantitation (10 ng/mL) for all the amphetamine derivatives. No interfering substances were detected. A stability study of these compounds in oral fluid stored at three different temperatures (-18, 4 and 20 degrees C) over 10 weeks was conducted, showing a time-dependent degradation of the four compounds. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:221 / 226
页数:6
相关论文
共 17 条
[1]  
Clauwaert KM, 2000, CLIN CHEM, V46, P1968
[2]   Stability study of the designer drugs "MDA, MDMA and MDEX" in water, serum, whole blood, and urine under various storage temperatures [J].
Clauwaert, KM ;
Van Bocxlaer, JF ;
De Leenheer, AP .
FORENSIC SCIENCE INTERNATIONAL, 2001, 124 (01) :36-42
[3]   SALIVA TESTING FOR DRUGS OF ABUSE [J].
CONE, EJ .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 694 :91-127
[4]   Determination of MDMA, MDEA and MDA in urine by high performance liquid chromatography with fluorescence detection [J].
da Costa, JL ;
Chasin, AAD .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 811 (01) :41-45
[5]  
*DEL GOB NACL DROG, 2003, 6 MININT DEL GOB NAC
[6]  
GARRETT ER, 1991, ACTA PHARM NORDICA, V3, P9
[7]   Sensitive determination of methylenedioxylated amphetamines by liquid chromatography [J].
Herráez-Hernández, R ;
Campíns-Falcó, P ;
Verdú-Andrés, J .
ANALYST, 2001, 126 (05) :581-586
[8]   High-performance liquid chromatography with fluorescence detection for the simultaneous determination of 3,4-methylenedioxymethamphetamine, methamphetamine and their metabolites in human hair using DIB-CI as a label [J].
Kaddoumi, A ;
Kikura-Hanajiri, R ;
Nakashima, K .
BIOMEDICAL CHROMATOGRAPHY, 2004, 18 (03) :202-204
[9]   Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration [J].
Kintz, P .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1997, 21 (07) :570-575
[10]   Simple and reliable high-performance liquid chromatography fluorimetric procedure for the determination of amphetamine-derived designer drugs [J].
Mancinelli, R ;
Gentili, S ;
Guiducci, MS ;
Macchia, T .
JOURNAL OF CHROMATOGRAPHY B, 1999, 735 (02) :243-253